anayamalik, Author at European Medical Journal - Page 67 of 97

Premature Death Risk Doubled with Serious Mental Illness: New York Study

Adults with serious mental illness (SMI) living in New York City are dying significantly younger than their peers, according to a new study.

AI and Real-World Data Transform Cancer Prognosis

The power of explainable artificial intelligence (xAI) combined with multimodal real-world data (RWD) to improve cancer prognosis across multiple cancer types was explored in a new study.

Psychedelic Psychotherapy: Promise and Pitfalls

A new analysis of psychedelic-assisted psychotherapy (PAP) research calls for greater methodological rigor and ethical reflection as the field continues to evolve.

A Game-Changer for Precision Medicine in Rheumatoid Arthritis

The potential of high-content imaging as a game-changer for precision medicine in rheumatoid arthritis (RA) has been highlighted in a new study.

Strengthening Vaccine Strategies for Mpox

Recent research into monkeypox (mpox) highlights critical gaps in vaccination coverage and infectious disease preparedness, raising concerns about future outbreaks.

LS-SCLC Immunotherapy Treatment Recommended for Approval

A new treatment for limited-stage small cell lung cancer (LS-SCLC) has been recommended for approval in the European Union following positive results from a Phase III trial.

How AI is Simplifying CPR Education

AI is playing an increasingly vital role in the dissemination of medical guidelines, especially in critical areas such as cardiopulmonary resuscitation (CPR).

Prescribing Podcasts For Stroke Recovery

Podcasts are emerging as an innovative solution for patient education, according to an abstract presented at the International Stroke Conference held in Los Angeles, California, USA.

Lung Cancer Screening: Precision versus Simplicity

In the battle against lung cancer, a recent editorial examines the effectiveness of risk prediction models in determining screening eligibility.

Vimentin Autoantibodies Linked to Novel CNS Disorder

A novel autoimmune meningoencephalomyelitis associated with autoantibodies targeting the astrocytic intermediate filament protein vimentin has been identified in a recent case series.